.
.
.
.
Coronavirus

Global supply of COVID-19 vaccines ‘incredibly tight’: Gavi

Published: Updated:

The global supply of COVID-19 vaccine is “incredibly tight” and the COVAX dose-sharing facility is unlikely to procure much more supply in 2021 than doses already reserved, the Gavi vaccine alliance CEO Seth Berkley said on Thursday.

Read the latest updates in our dedicated coronavirus section.

“We urgently need commitments of a further $2 billion from donors and $1 billion from countries supported by multilateral development banks. Included in the $2 billion we ask for is $150 million from the private sector,” Berkley told an event, referring to a funding target for June.

Stanley Erck, Novavax CEO, said that the US-based company had vaccine production capabilities in more than 20 facilities and that it was “well on our way to securing regulatory authorizations around the world”.

Read more:

WHO: Europe has surpassed 1 million COVID-19 deaths

WHO worries COVID-19 could worsen during Ramadan

Former leaders urge US to waive vaccine intellectual property rules